Concepedia

Koen Dudink

KD

Statistics

Publications

4

Citations

97

H-Index

4

Active since

2021

Affiliations

Erasmus MC(Current)

University of Groningen

University Medical Center Groningen

Koen Dudink is an author at Erasmus MC specializing in clinical pharmacology, medicine, and pharmacotherapy.

ORCID

Publications per year

2021–2023

4

Publications

4

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study

Koen Dudink, Klasiena Bouwman, Yanqing Chen et al. · British Journal of Dermatology · 2023 · 38 citations · Full text

, , +9

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study*

Lisette M. Prens, Klasiena Bouwman, Pim Aarts et al. · British Journal of Dermatology · 2021 · 35 citations · Full text

, , +14

A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (<scp>GERAS</scp>study)

Nadja E. Zorge, Eveline R Y Scheerders, Koen Dudink et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 12 citations · Full text

, , +14

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study

Klasiena Bouwman, Pim Aarts, Koen Dudink et al. · American Journal of Clinical Dermatology · 2022 · 12 citations · Full text

, , +10

1–4 of 4